Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Abstract Text:

D Michael Hallman,Sathanur R Srinivasan,Wei Chen,Eric Boerwinkle,Gerald S Berenson,

Polymorphisms in the APOC3 and APOA5 genes, from the APOA1/APOC3/APOA4/APOA5 gene cluster on chromosome 11q23, have been associated with interindividual variation in plasma triglycerides. APOA5 polymorphisms implicated include 2 in the promoter region (-1131 T/C and -3 A/G) and 1 in exon 2 (+56 C/G). APOC3 polymorphisms implicated include 1 (SstI) in the 3' untranslated region and 1 (-2854 G/T) in the APOC3-APOA4 intergenic region. We analyzed the associations of haplotypes and multilocus genotypes of these polymorphisms on longitudinal serum triglyceride profiles in 360 African American and 823 white subjects from the Bogalusa Heart Study. Subjects were examined from 2 to 8 times (mean +/- SD, 5.4 +/- 1.3) between 1973 and 1996, at ages ranging from 4 to 38 years, with 1978 observations in African Americans and 4465 in whites. Serum triglycerides were significantly higher among whites across all ages. Allele frequencies differed significantly between African Americans and whites at all but the APOA5 +56 C/G locus. Linkage disequilibrium among the loci was higher in whites and haplotype diversity lower: 6 haplotypes had estimated frequencies of more than 1% in African Americans, 5 in whites. Individually, all polymorphisms except APOC3 -2854 G/T showed significant associations with triglyceride levels in the full sample. However, genotype models including all 5 loci showed significant triglyceride associations for only 3 (APOC3 SstI, APOA5 -1131 T/C, and APOA5 +56 C/G); significant interactions among them indicated their effects were not independent. Neither APOC3 -2854 G/T nor APOA5 -3 A/G had significant effects when the other 3 loci were in the models. The EM algorithm was used to estimate haplotype frequencies and assign haplotype probabilities to individuals, which is conditional on their genotypes; individuals' haplotype probability vectors were then used as predictors in multilevel mixed models of longitudinal triglyceride profiles. Of haplotypes comprising, in order, APOC3 SstI and -2854 G/T and APOA5 -1131 T/C, -3 A/G, and +56 C/G, 3 were significantly associated with higher triglycerides, even after adjusting for multiple tests: GGTAG (P = .002), GTTAG (P < .0001), and CGCGC (P = .0002). Each GGTAG haplotype carried would be expected to raise triglyceride levels (relative to those of GTTAC homozygotes) by approximately 19 mg/dL, each GTTAG haplotype by approximately 15 mg/dL, and each CGCGC haplotype by approximately 7 mg/dL. Haplotypes comprising the 3 loci implicated by genotype analyses (SstI, -1131 T/C, and +56 C/G) were also tested: haplotypes C_C_C and G_T_G significantly raised triglycerides, even after adjustment for multiple comparisons (P < .002 for both), with each copy of C_C_C expected to raise triglycerides by approximately 7 mg/dL and each copy of G_T_G by approximately 15 mg/dL. Overall, our findings support those of others in associating specific polymorphisms and haplotypes in the APOA1/C3/A4/A5 gene cluster with higher serum triglyceride levels. However, the degree to which polymorphisms in the APOC3 and APOA5 genes may be independently associated with triglyceride levels remains to be determined.

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Publishing Authors By Initials

DM Hallman,SR Srinivasan,W Chen,E Boerwinkle,GS Berenson,

For similar lipids: glycerides: triglycerides research abstracts see: lipids: glycerides: triglycerides research

PUBMED ID PMID:

MEDLINE DATE:

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Metabolism: clinical and experimental

VOLUME: 55

Page Numbers: 1574-81

Journal Abbreviation: Metab. Clin. Exp.

ISSN: 0026-0495

DAY: 3

MONTH: Dec

YEAR: 2006

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 375267

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Keywords Mesh Terms:

KEYWORDS: Triglycerides

MESH TERMS: blood

Chemical & Substance for Abstract: Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study. Information

Substance Name: Triglycerides

Registry Number: 0

Grant and Affiliation Information for Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.

AFFILIATION: Human Genetics Center, University of Texas, Houston Health Science Center, Houston, TX 77225, USA. d.michael.hallman@uth.tmc.edu

Country: United States

AGENCY: United States NHLBI

GRANT: HL70568

ACRONYM: HL

MEDLINETA: Metabolism

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study Related Publications

• A genome scan for loci influencing levels and trends of lipoprotein lipid-related traits since childhood: The Bogalusa Heart Study.
• Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
• Association of calcium intake, dairy product consumption with overweight status in young adults (1995-1996): the Bogalusa Heart Study.
• Beta-adrenergic receptor genes are associated with arterial stiffness in black and white adults: the bogalusa heart study.
• Beyond the campus: unacknowledged rape among low-income women.
• Body image and risky sexual behaviors: An investigation in a tri-ethnic sample.
• Cardiovascular risk factors among internal medicine residents.
• Clustering of long-term trends in metabolic syndrome variables from childhood to adulthood in Blacks and Whites: the Bogalusa Heart Study.
• Comparison of the measures of pulsatile arterial function between asymptomatic younger adult smokers and former smokers: the Bogalusa Heart Study.
• Correlates of anxiety symptoms during pregnancy and association with perinatal outcomes: a meta-analysis.
• Correlates of vascular structure and function measures in asymptomatic young adults: the Bogalusa Heart Study.
• Does food group consumption vary by differences in socioeconomic, demographic, and lifestyle factors in young adults? The Bogalusa Heart Study.
• Epidemiologic investigations of cardiovascular risk factor variables in childhood--an overview.
• From politics to policy: a new payment approach in medicare advantage.
• G-6A polymorphism of angiotensinogen gene modulates the effect of blood pressure on carotid intima-media thickness. The Bogalusa Heart Study.
• Influence of lipoprotein lipase gene Ser447Stop and beta1-adrenergic receptor gene Arg389Gly polymorphisms and their interaction on obesity from childhood to adulthood: the Bogalusa Heart Study.
• Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
• Path analysis of metabolic syndrome components in black versus white children, adolescents, and adults: the bogalusa heart study.
• Persistent elevation of liver function enzymes within the reference range is associated with increased cardiovascular risk in young adults: the Bogalusa Heart Study.
• Predictors of left ventricular dilatation in young adults (from the Bogalusa Heart Study).
• Psychosocial influences on cigarette smoking among youth in a southern community: the Bogalusa Heart Study.
• Race (black-white) and gender divergences in the relationship of childhood cardiovascular risk factors to carotid artery intima-media thickness in adulthood: the Bogalusa Heart Study.
• Racial (black-white) divergence in the association between adiponectin and arterial stiffness in asymptomatic young adults: the bogalusa heart study.
• Recovery after inadvertent massive overdosage of vincristine (NSC-67574).
• Relation of body mass index and waist-to-height ratio to cardiovascular disease risk factors in children and adolescents: the Bogalusa Heart Study.
• Relative impact of young adult personality disorders on subsequent quality of life: findings of a community-based longitudinal study.
• Separating fact from fiction: a new role for health affairs.
• Sexual and physical abuse history and adult sexual risk behaviors: relationships among women and potential mediators.
• Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study).
• Value of Routine Fluorograms as a Measure for Detecting Cardiac Abnormalities - Report of Findings on 14,235 Routine (35mm) Photofluorograms.